129 related articles for article (PubMed ID: 34251002)
1. Substance P containing peptide gene delivery vectors for specifically transfecting glioma cells mediated by a neurokinin-1 receptor.
Ding G; Wang T; Han Z; Tian L; Cheng Q; Luo L; Zhao B; Wang C; Feng S; Wang L; Meng Z; Meng Q
J Mater Chem B; 2021 Aug; 9(32):6347-6356. PubMed ID: 34251002
[TBL] [Abstract][Full Text] [Related]
2. Improving NK1R-targeted gene delivery of stearyl-antimicrobial peptide CAMEL by conjugating it with substance P.
Song J; Huang S; Ma P; Zhang B; Jia B; Zhang W
Bioorg Med Chem Lett; 2020 Aug; 30(16):127353. PubMed ID: 32631551
[TBL] [Abstract][Full Text] [Related]
3. Peptide Gene Delivery Vectors for Specific Transfection of Glioma Cells.
Wang T; Meng Z; Kang Z; Ding G; Zhao B; Han Z; Zheng Z; Wang C; Meng Q
ACS Biomater Sci Eng; 2020 Dec; 6(12):6778-6789. PubMed ID: 33320593
[TBL] [Abstract][Full Text] [Related]
4. The structure and configuration changes of multifunctional peptide vectors enhance gene delivery efficiency.
Yang S; Meng Z; Kang Z; Sun C; Wang T; Feng S; Meng Q; Liu K
RSC Adv; 2018 Aug; 8(50):28356-28366. PubMed ID: 35542475
[TBL] [Abstract][Full Text] [Related]
5. Transferrin receptor targeting segment T7 containing peptide gene delivery vectors for efficient transfection of brain tumor cells.
Kang Z; Zeng C; Tian L; Wang T; Yang S; Cheng Q; Zhang J; Meng Q; Zhang C; Meng Z
Drug Deliv; 2022 Dec; 29(1):2375-2385. PubMed ID: 35866298
[TBL] [Abstract][Full Text] [Related]
6. Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy.
Cordier D; Gerber A; Kluba C; Bauman A; Hutter G; Mindt TL; Mariani L
Cancer Biother Radiopharm; 2014 Jun; 29(5):221-6. PubMed ID: 24552486
[TBL] [Abstract][Full Text] [Related]
7. Histidine-enriched multifunctional peptide vectors with enhanced cellular uptake and endosomal escape for gene delivery.
Meng Z; Luan L; Kang Z; Feng S; Meng Q; Liu K
J Mater Chem B; 2017 Jan; 5(1):74-84. PubMed ID: 32263436
[TBL] [Abstract][Full Text] [Related]
8. Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with
Majkowska-Pilip A; Koźmiński P; Wawrzynowska A; Budlewski T; Kostkiewicz B; Gniazdowska E
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301182
[TBL] [Abstract][Full Text] [Related]
9. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
10. Enhanced blood-brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system.
Yao H; Wang K; Wang Y; Wang S; Li J; Lou J; Ye L; Yan X; Lu W; Huang R
Biomaterials; 2015 Jan; 37():345-52. PubMed ID: 25453963
[TBL] [Abstract][Full Text] [Related]
11. Enhanced gene transfection efficiency by use of peptide vectors containing laminin receptor-targeting sequence YIGSR.
Meng Z; Kang Z; Sun C; Yang S; Zhao B; Feng S; Meng Q; Liu K
Nanoscale; 2018 Jan; 10(3):1215-1227. PubMed ID: 29292451
[TBL] [Abstract][Full Text] [Related]
12. NK1R/5-HT1AR interaction is related to the regulation of melanogenesis.
Wu H; Zhao Y; Huang Q; Cai M; Pan Q; Fu M; An X; Xia Z; Liu M; Jin Y; He L; Shang J
FASEB J; 2018 Jun; 32(6):3193-3214. PubMed ID: 29430989
[TBL] [Abstract][Full Text] [Related]
13. Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.
Palma C; Nardelli F; Manzini S; Maggi CA
Br J Cancer; 1999 Jan; 79(2):236-43. PubMed ID: 9888463
[TBL] [Abstract][Full Text] [Related]
14. Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.
Spitsin S; Tuluc F; Meshki J; Ping Lai J; Tustin Iii R; Douglas SD
Neuroimmunomodulation; 2013; 20(5):247-55. PubMed ID: 23921645
[TBL] [Abstract][Full Text] [Related]
15. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
16. A non-viral suicide gene delivery system traversing the blood brain barrier for non-invasive glioma targeting treatment.
Gao S; Tian H; Xing Z; Zhang D; Guo Y; Guo Z; Zhu X; Chen X
J Control Release; 2016 Dec; 243():357-369. PubMed ID: 27794494
[TBL] [Abstract][Full Text] [Related]
17. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral Cascade-Targeting Ligand for IL-6 Receptor-Mediated Gene Delivery to Glioma.
Wang S; Reinhard S; Li C; Qian M; Jiang H; Du Y; Lächelt U; Lu W; Wagner E; Huang R
Mol Ther; 2017 Jul; 25(7):1556-1566. PubMed ID: 28502470
[TBL] [Abstract][Full Text] [Related]
19. Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.
Lai JP; Lai S; Tuluc F; Tansky MF; Kilpatrick LE; Leeman SE; Douglas SD
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12605-10. PubMed ID: 18713853
[TBL] [Abstract][Full Text] [Related]
20. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
